https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/funding-provided-develop-new-therapy-acute-liver-failure/
Funding provided to develop new therapy for acute liver failure
9 Sep 2015, 4:50 p.m.
BRC-supported researcher Dr Kevin Mills has been awarded funding from the NIHR to investigate the regenerative ability of the liver following acute liver failure (ALF). If successful, the team hope that their research will lead to a novel therapy that could buy patients enough time to allow their livers to regenerate naturally, avoiding the need for liver transplantsThis research will be led by Professor Anil Dhawan at Kings College London in collaboration with Dr Mills at UCL Institute of Child Health. Specifically, the team aim to develop a novel technique where human liver cells grown in the lab are encapsulated in a material called alginate and delivered to a patient to help their ailing liver regenerate. Encasing the liver cells in alginate is particularly important as it reduces the need for immunosuppression.
Studies in the lab will focus on the feasibility of this novel therapy under lab conditions.
Dr Ian Simcock becomes GOSH’s first Allied Health Professional to receive NIHR postdoctoral fellowship
The five-year fellowship will focus on improving parental choice after pregnancy loss through the development of less-invasive post-mortem investigations.
National conference brings child health research community together
Researchers and clinicians from across the UK gathered at Sheffield City Hall for the inaugural National Paediatric Translational Research Conference
Mum chooses to support research as a legacy for her twins
Understanding how a singular cancer spread between two twins in the womb using genomics - Research from GOSH and the Sanger Institute
World-first same-day metagenomics for children can detect hidden infections in intensive care
GOSH has successfully implemented a pioneering same-day respiratory metagenomics testing service for children in intensive care, helping clinicians identify infections more quickly and make better-informed treatment decision